STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more
Acadia Pharmaceuticals disclosed that Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.
Top of the morning to you, and a fine one it is. Sunny skies and a crisp breeze are wafting over the Pharmalot campus, where the official mascots are roaming about in search of
